Millipore Sigma Vibrant Logo

513035 PD 158780 - CAS 171179-06-9 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
171179-06-9C₁₄H₁₂BrN₅

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
513035-500UG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 500 μg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA potent, cell-permeable, reversible, ATP-competitive inhibitor of the EGFR tyrosine kinase activity (IC50 = 8 pM). Also inhibits heregulin-stimulated autophosphorylation in SK-BR-3 (IC50 = 49 nM) and MDA-MB-453 (IC50 = 52 nM) breast carcinomas. The inhibition is competitive and results from binding of the inhibitor at the ATP site of the enzymes. Inhibits the LPA-stimulated MAP kinase kinase 1/2 (MKK1/2) activation and EGFR tyrosine phosphorylation in HeLa and NIH 3T3 cells. A 10 mM (500 µg/151 µl) solution of PD 158780 (Cat. No. 513036) in DMSO is also available.
      Catalogue Number513035
      Brand Family Calbiochem®
      Synonyms4-[(3-Bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyridimine
      References
      ReferencesCunnick, J.M., et al. 1998. J. Biol. Chem. 273, 14468.
      Rewcastle, G.W., et al. 1998. J. Med. Chem. 41, 742.
      Product Information
      CAS number171179-06-9
      ATP CompetitiveY
      FormYellow solid
      Hill FormulaC₁₄H₁₂BrN₅
      Chemical formulaC₁₄H₁₂BrN₅
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetEGFR tyrosine kinase
      Primary Target IC<sub>50</sub>8 pM against EGFR tyrosine kinase activity; 49 nM, 52 nm, against heregulin-stimulated autophosphorylation in SK-BR-3 and MDA-MB-453 breast carcinomas, respectively
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      513035-500UG 04055977198645

      Documentation

      PD 158780 - CAS 171179-06-9 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      PD 158780 - CAS 171179-06-9 - Calbiochem Analysenzertifikate

      TitelChargennummer
      513035

      Literatur

      Übersicht
      Cunnick, J.M., et al. 1998. J. Biol. Chem. 273, 14468.
      Rewcastle, G.W., et al. 1998. J. Med. Chem. 41, 742.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision12-January-2010 RFH
      Synonyms4-[(3-Bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyridimine
      DescriptionA potent, cell-permeable, reversible, ATP-competitive inhibitor of the EGFR tyrosine kinase activity (IC50 = 8 pM). Also inhibits heregulin-stimulated autophosphorylation in SK-BR-3 (IC50 = 49 nM) and MDA-MB-453 (IC50 = 52 nM) breast carcinomas. The inhibition is competitive and results from binding of the inhibitor at the ATP site of the enzymes. Inhibits the LPA-stimulated MAP kinase kinase ½ (MKK½) activation and EGFR tyrosine phosphorylation in HeLa and NIH3T3 cells.
      FormYellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number171179-06-9
      Chemical formulaC₁₄H₁₂BrN₅
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze at -20°C. Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesCunnick, J.M., et al. 1998. J. Biol. Chem. 273, 14468.
      Rewcastle, G.W., et al. 1998. J. Med. Chem. 41, 742.